FIELD: medicine, pharmaceutics.
SUBSTANCE: declared invention refers to chemical-pharmaceutical industry, and concerns 2-phenyl-3-(3,4-dimethoxyphenyl)-4-(2-morpholinoethyl)pyrrolo[1,2-a]benzimidazole sulphate of formula (I) 
possessing antiradical activity, cerebroprotective and antiischemic properties and applicable as an active principle of drug preparations for prevention and therapy of cerebral ischemic injures.
EFFECT: agent provides higher clinical effectiveness in acute cerebral ischemic injury.
4 ex, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 2-(3,4-DIHYDROXYPHENYL)-9-DIETHYLAMINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE DIHYDROBROMIDE AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2391979C2 |
| AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
| ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT POTASSIUM COMENATE | 2012 |
|
RU2514632C1 |
| DRUG POSSESSING ANTIHYPOXIC, ACTOPROTECTIVE, NOOTROPIC ACTIVITIES AND HAVING EFFECT ON PHYSICAL EFFICIENCY, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2462245C1 |
| ANTIOXIDANT, STRESS AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT SODIUM COMENATE | 2012 |
|
RU2506078C1 |
| METHOD FOR PREPARING LITHIUM SALT OF COMENIC ACID AND USING IT AS ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE AGENT | 2011 |
|
RU2477722C1 |
| MEDICATION WHICH POSSESSES ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2440814C1 |
| NEUROPROTECTIVE PHARMACEUTICAL AGENT | 2013 |
|
RU2528914C1 |
| 2-ARYL-4-DIALKYLAMINOETHYL-3-PHENYLPYRROLO[1,2-a]-BENZIMIDAZOLE SULPHATES, HAVING ANTIOXIDANT AND ANTIRADICAL PROPERTIES | 2010 |
|
RU2443704C1 |
| METHOD OF STRUCTURAL VESSEL ALTERATION CORRECTION IN EXPERIMENT | 2007 |
|
RU2349320C2 |
